SM
Sullivan Mark
Officier
OtherM
内部人交易记录
其他尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the full record of transactions filed by Sullivan Mark, Officier. Officer active across 3 companies, notably Sesen Bio, Inc.. In total, 18 disclosures have been published. Breakdown: 0 buy · 11 sells. Total volume traded: €752k. Activity tracked since 18 February 2022. The latest transaction was filed on 14 September 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Sullivan Mark
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报18 总计
125,000 股0Common SharesSEC:0001193125-26-389889:0
62,500 股0Common SharesSEC:0001193125-26-345837:0
13,008 股Common SharesSEC:0001193125-26-285567:0
62,500 股Common SharesSEC:0001193125-26-276879:0
10,702 股@ US$18.47100.0% 占其流量Common SharesSEC:0001193125-26-126827:0
125,000 股0Common SharesSEC:0001193125-26-039579:0
11,276 股@ US$13.146924.9% 占其流量Common SharesSEC:0001193125-25-335481:0
11,278 股@ US$9.7724.9% 占其流量Common SharesSEC:0001193125-25-220848:0
11,491 股@ US$6.8023.5% 占其流量Common SharesSEC:0000950170-25-090431:0
6,576 股@ US$6.7418.9% 占其流量Common SharesSEC:0000950170-25-045394:0
150,000 股0Common SharesSEC:0000950170-25-038798:0
4,519 股@ US$7.4314.8% 占其流量Common SharesSEC:0001104659-24-132160:0
4,430 股@ US$5.9810.9% 占其流量Common SharesSEC:0000950170-24-109447:0
17,854 股@ US$7.2255.3% 占其流量Common SharesSEC:0000950170-24-077497:0
200,000 股0Common SharesSEC:0001209191-23-024335:0
100,978 股@ US$0.58771.7% 占其流量Common StockSEC:0001485003-23-000111:0
39,831 股@ US$0.587328.3% 占其流量Common StockSEC:0001485003-23-000066:0
339,525 股0Common StockSEC:0001485003-22-000022:0
About Sullivan Mark
Sullivan Mark is an Officier associated with Mind Medicine (MindMed) Inc., Definium Therapeutics, Inc., and Sesen Bio, Inc., where he is Chief Legal Officer, Chief Legal Officer, and General Counsel & Secretary. Across 16 filings in total, the 16 sampled filings, from 2022-02-23 to 2026-06-26, are sale transactions totaling EUR 752260, including EUR 170186.4167376335 at Definium Therapeutics, Inc. and EUR 125786.8981395954, EUR 120364.5747956384, EUR 94476.8323022514, EUR 66878.2187585699 at Mind Medicine (MindMed) Inc., as well as EUR 55557.60340857484 at Sesen Bio, Inc.